Modulation of the tumor microvasculature by phosphoinositide-3 kinase inhibition increases doxorubicin delivery in vivo. (2012)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-11-1413
PubMed Identifier: 22065081
Publication URI: http://europepmc.org/abstract/MED/22065081
Type: Journal Article/Review
Volume: 18
Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research
Issue: 1
ISSN: 1078-0432